The news about how well retatrutide works came this month from Eli Lilly, the drugs manufacturer
Bailey, M, Meyerson, WU, Dursi, LJ, Wang, LB, Dong, G, Liang, WW, Weerasinghe, A, Li, S, Kelso, S, Akbani, R, Anur, P, Bailey, MH, Buchanan, A, Chiotti, K, Covington, KR, Creason, A, Ding, L, Ellrott, K, Huse, J, Wang, W, Weinstein, JN, Chen, K, Chong, Z, Akdemir, KC, Aldape, KD, Cao, S, Chakravarty, D, Chen, Y, Chong, Z, Czerniak, BA, El-Naggar, AK, Fan, Y, Futreal, A, Gershenwald, JE, Han, L, von Kalle, C, Krishnamurthy, S, Lazar, A, Li, J, Liang, H, Lichter, P, Lu, Y, Park, K, Sood, AK, Su, X, Thompson, A, Van Loo, P, Wang, L , Yuan, Y, Zhu, H
Ibarra-Rubio ME
doi:10.1291/hypres.28.209
(2010) The angiotensin IV analog Nle-Tyr-Leu-psi-(CH2-NH2)3-4-His-Pro-Phe (norleual) can act as a hepatocyte growth factor/c-Met inhibitor